PortfoliosLab logo

Aprea Therapeutics, Inc. (APRE)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Aprea Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $115 for a total return of roughly -98.85%. All prices are adjusted for splits and dividends.

APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with APRE

Aprea Therapeutics, Inc.


Aprea Therapeutics, Inc. had a return of -29.00% year-to-date (YTD) and -86.65% in the last 12 months. Over the past 10 years, Aprea Therapeutics, Inc. had an annualized return of -72.39%, while the S&P 500 had an annualized return of 9.41%, indicating that Aprea Therapeutics, Inc. did not perform as well as the benchmark.

1 month-7.84%0.19%
6 months-66.90%7.70%
1 year-86.65%-12.45%
5 years (annualized)-72.39%9.41%
10 years (annualized)-72.39%9.41%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aprea Therapeutics, Inc. Sharpe ratio is -0.05. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Aprea Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aprea Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aprea Therapeutics, Inc. is 99.95%, recorded on Feb 13, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.95%Dec 30, 2019787Feb 13, 2023
-24.77%Nov 20, 20195Nov 26, 20199Dec 10, 201914
-17.45%Dec 13, 20194Dec 18, 20194Dec 24, 20198
-8.92%Oct 22, 20197Oct 30, 201911Nov 14, 201918
-7.61%Oct 4, 20193Oct 8, 20198Oct 18, 201911
-0.9%Nov 18, 20191Nov 18, 20191Nov 19, 20192

Volatility Chart

Current Aprea Therapeutics, Inc. volatility is 31.88%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)